Answers are grounded in this paper and cite their sources.
The chemistry of [Re(CO)(NO)L2] fragments (L phosphorus donor) was explored. Starting from [Re(CO)5Cl] the synthesis of [Re2Cl2(μ‐Cl)2(CO)4(NO)2] (1) was accomplished via the preparation of [Et4N]2[Re2Cl2(μ‐Cl)2(CO)6] and nitrosylation of this compound with [NO][BF4]. Complex 1 was converted to [RecL2(CO)(NO)L2] complexes 2 (a L = (MeO)3P; b L = (EtO)3P; c L = (i‐PrO)3P; d L Me3P; e L Et3P; f L Cy3P) by heating with L in MeCN. In the case of the reaction of L = (MeO)3P, a trisubstitued compound mer‐{ReCl2(NO)[P(OMe)3]3} 3 was also obtained. Replacement of the Cl ligands in 2a–e with Me groups was achieved by reacting them with MeLi in Et2O yielding cis, trans‐[Re(CO)(NO)Me2L2]complexes 4a–e. Reaction of 2a–e with Li[BHEt3] led to substitution of one Cl by an H ligand with formation of [ReCl(CO)H(NO)L2] compounds 5a–;e, displaying trans‐H,NO geometries. The hydride‐transfer agent Na[AlH2(OCH2CH2OCH3)2] transformed 2 into the cis‐dihydride systems [Re(CO)H2(NO)L2] 6a–f. Reductive carbonylation of 2a–d in the presence of Na/Hg and CO gave pentacoordinate [Re(CO)2(NO)L2] complexes 7b–d, and under comparable conditions the Cl substituents of 2b–f were replaced by tolane using Mg or t‐BuLi giving trigonal bipyramidal [Re(CO)(NO)L2(PhCCPh)] compounds 8b–f. Complexes 5c, 6a, and 8d were characterized by X‐ray crystal‐structure analysis.
No takes yet. Share an insight, caveat, or question.
Hund et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: